Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.
Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 857
Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Drugs In Development, 2021, provides....
Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 1416
Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Drugs In Development, 2021, provides an overview....
Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 329
Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia - Drugs In Development, 2021, provides an overview of the Hypercholesterolemia (Metabolic....
Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 123
Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Heterozygous familial hypercholesterolemia - Drugs In Development, 2021, provides an....
Obesity (Metabolic Disorder) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 763
Obesity (Metabolic Disorder) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Drugs In Development, 2021, provides an overview of the Obesity (Metabolic....
